市場調査レポート

商品コード

1178009

バーチャル臨床試験の世界市場：試験デザイン別、適応症別、地域別（2022年～2032年）

Global Virtual Clinical Trials Market by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Others), and by Region - 2022 to 2032

出版日: 2022年11月09日 | 発行: Transparency Market Research

| ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,424円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,704円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,984円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界のバーチャル臨床試験市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、試験デザイン別・適応症別・地域別の分析、および競合情勢などを提供しています。

市場力学
- 促進要因
- 抑制要因
- 機会
- 動向
シナリオ予測
- 楽観的シナリオでの需要
- 予想されるシナリオでの需要
- 保守的なシナリオでの需要
機会マップ分析
サプライチェーン分析
投資実現可能性マトリックス
PESTLEとポーターの分析
規制状況
- 主要地域別
- 主要国別

第4章世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）

過去の市場規模、金額分析（2017年～2021年）
現在および将来の市場規模、金額予測（2022年～2032年）
- 前年比成長トレンド分析
- 絶対的な機会分析

第5章世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：試験デザイン別

イントロダクション/ 主な調査結果
過去の市場規模、金額分析、試験デザイン別（2017年～2021年）
現在および将来の市場規模、金額の分析・予測、試験デザイン別（2022年～2032年）
- 介入試験
- 観察試験
- 拡張参加試験
前年比成長トレンド分析、試験デザイン別（2017年～2021年）
絶対的な機会分析、試験デザイン別（2022年～2032年）

第6章世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：適応別

イントロダクション/ 主な調査結果
過去の市場規模、金額分析、適応症別（2017年～2021年）
現在および将来の市場規模、金額分析・予測、適応症別（2022年～2032年）
- 腫瘍
- 循環器
- その他
前年比成長トレンド分析、適応症別（2017年～2021年）
絶対的な機会分析、適応症別（2022年～2032年）

第7章世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：地域別

イントロダクション
過去の市場規模、金額分析、地域別（2017年～2021年）
現在の市場規模、金額分析・予測、地域別（2022年～2032年）
- 北米
- ラテンアメリカ
- 欧州
- 東アジア
- 南アジア
- オセアニア
- 中東・アフリカ
市場魅力分析、地域別

第8章北米のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第9章ラテンアメリカのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第10章欧州のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第11章東アジアのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第12章南アジアのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第13章オセアニアのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第14章中東・アフリカのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第15章主要国のバーチャル臨床試験市場分析

米国
- 価格分析
- 市場シェア分析、2021年
カナダ
- 価格分析
- 市場シェア分析、2021年
ブラジル
- 価格分析
- 市場シェア分析、2021年
メキシコ
- 価格分析
- 市場シェア分析、2021年
アルゼンチン
- 価格分析
- 市場シェア分析、2021年
ドイツ
- 価格分析
- 市場シェア分析、2021年
イタリア
- 価格分析
- 市場シェア分析、2021年
フランス
- 価格分析
- 市場シェア分析、2021年
英国
- 価格分析
- 市場シェア分析、2021年
スペイン
- 価格分析
- 市場シェア分析、2021年
ロシア
- 価格分析
- 市場シェア分析、2021年
ベネルクス
- 価格分析
- 市場シェア分析、2021年
中国
- 価格分析
- 市場シェア分析、2021年
日本
- 価格分析
- 市場シェア分析、2021年
韓国
- 価格分析
- 市場シェア分析、2021年
インド
- 価格分析
- 市場シェア分析、2021年
タイ
- 価格分析
- 市場シェア分析、2021年
マレーシア
- 価格分析
- 市場シェア分析、2021年
インドネシア
- 価格分析
- 市場シェア分析、2021年
オーストラリア
- 価格分析
- 市場シェア分析、2021年
ニュージーランド
- 価格分析
- 市場シェア分析、2021年
GCC諸国
- 価格分析
- 市場シェア分析、2021年

第16章市場構造分析

競合ダッシュボード
競合ベンチマーク
主要企業の市場シェア分析
- 地域別
- 試験デザイン別
- 適応症別

第17章競合分析

競合の詳細
- ICON, plc
- Parexel International Corporation
- IQVIA
- Covance
- PRA Health Sciences
- LEO Innovation Lab
- Medidata
- Oracle
- CRF Health
- Clinical Ink
- Medable, Inc.

第18章前提条件と頭字語の使用

第19章調査手法

図表

List of Tables

Table 1: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 3: Global Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 4: North America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 6: North America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 7: Latin America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 9: Latin America Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 10: Europe Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 12: Europe Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 13: East Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: East Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 15: East Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 16: South Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: South Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 18: South Asia Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 19: Oceania Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Oceania Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 21: Oceania Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 22: MEA Virtual Clinical Trials Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 23: MEA Virtual Clinical Trials Market Value (US$ Mn) Forecast by Study Design, 2017-2032
Table 24: MEA Virtual Clinical Trials Market Value (US$ Mn) Forecast by Indication, 2017-2032

List of Figure

Figure 1: Global Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 2: Global Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 3: Global Virtual Clinical Trials Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Virtual Clinical Trials Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 8: Global Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 9: Global Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 10: Global Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 11: Global Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 12: Global Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 13: Global Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 14: Global Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 15: Global Virtual Clinical Trials Market Attractiveness by Region, 2022-2032
Figure 16: North America Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 17: North America Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 18: North America Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 23: North America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 24: North America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 25: North America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 26: North America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 27: North America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 28: North America Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 29: North America Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 30: North America Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 32: Latin America Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 33: Latin America Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 38: Latin America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 39: Latin America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 40: Latin America Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 41: Latin America Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 42: Latin America Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 43: Latin America Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 44: Latin America Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 45: Latin America Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
Figure 46: Europe Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 47: Europe Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 48: Europe Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 53: Europe Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 54: Europe Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 55: Europe Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 56: Europe Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 57: Europe Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 58: Europe Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 59: Europe Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 60: Europe Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
Figure 61: East Asia Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 62: East Asia Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 63: East Asia Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 64: East Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: East Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: East Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: East Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 68: East Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 69: East Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 70: East Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 71: East Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 72: East Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 73: East Asia Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 74: East Asia Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 75: East Asia Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
Figure 76: South Asia Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 77: South Asia Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 78: South Asia Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 79: South Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: South Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: South Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: South Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 83: South Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 84: South Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 85: South Asia Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 86: South Asia Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 87: South Asia Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 88: South Asia Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 89: South Asia Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 90: South Asia Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
Figure 91: Oceania Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 92: Oceania Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 93: Oceania Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 94: Oceania Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: Oceania Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 96: Oceania Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 97: Oceania Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 98: Oceania Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 99: Oceania Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 100: Oceania Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 101: Oceania Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 102: Oceania Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 103: Oceania Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 104: Oceania Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 105: Oceania Virtual Clinical Trials Market Attractiveness by Country, 2022-2032
Figure 106: MEA Virtual Clinical Trials Market Value (US$ Mn) by Study Design, 2022-2032
Figure 107: MEA Virtual Clinical Trials Market Value (US$ Mn) by Indication, 2022-2032
Figure 108: MEA Virtual Clinical Trials Market Value (US$ Mn) by Country, 2022-2032
Figure 109: MEA Virtual Clinical Trials Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 110: MEA Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 111: MEA Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 112: MEA Virtual Clinical Trials Market Value (US$ Mn) Analysis by Study Design, 2017-2032
Figure 113: MEA Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Study Design, 2022-2032
Figure 114: MEA Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Study Design, 2022-2032
Figure 115: MEA Virtual Clinical Trials Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 116: MEA Virtual Clinical Trials Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 117: MEA Virtual Clinical Trials Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 118: MEA Virtual Clinical Trials Market Attractiveness by Study Design, 2022-2032
Figure 119: MEA Virtual Clinical Trials Market Attractiveness by Indication, 2022-2032
Figure 120: MEA Virtual Clinical Trials Market Attractiveness by Country, 2022-2032

Product Code: TMRGL80368

TMR's report on the global virtual clinical trials market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global virtual clinical trials market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global virtual clinical trials market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the virtual clinical trials market.

The report delves into the competitive landscape of the global virtual clinical trials market. Key players operating in the global virtual clinical trials market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global virtual clinical trials market profiled in this report.

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Supply Chain Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter's Analysis
3.7. Regulatory Landscape
- 3.7.1. By Key Regions
- 3.7.2. By Key Countries

4. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis

5. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Study Design

5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Study Design, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Study Design, 2022-2032
- 5.3.1. Interventional
- 5.3.2. Observational
- 5.3.3. Expanded Access
5.4. Y-o-Y Growth Trend Analysis By Study Design, 2017-2021
5.5. Absolute $ Opportunity Analysis By Study Design, 2022-2032

6. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032
- 6.3.1. Oncology
- 6.3.2. Cardiovascular
- 6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

7. Global Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Region

7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. East Asia
- 7.3.5. South Asia
- 7.3.6. Oceania
- 7.3.7. MEA
7.4. Market Attractiveness Analysis By Region

8. North America Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 8.2.1. By Country
  - 8.2.1.1. U.S.
  - 8.2.1.2. Canada
- 8.2.2. By Study Design
- 8.2.3. By Indication
8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Study Design
- 8.3.3. By Indication
8.4. Key Takeaways

9. Latin America Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
  - 9.2.1.1. Brazil
  - 9.2.1.2. Mexico
  - 9.2.1.3. Argentina
  - 9.2.1.4. Rest of Latin America
- 9.2.2. By Study Design
- 9.2.3. By Indication
9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Study Design
- 9.3.3. By Indication
9.4. Key Takeaways

10. Europe Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
  - 10.2.1.1. Germany
  - 10.2.1.2. Italy
  - 10.2.1.3. France
  - 10.2.1.4. U.K.
  - 10.2.1.5. Spain
  - 10.2.1.6. Russia
  - 10.2.1.7. BENELUX
  - 10.2.1.8. Rest of Europe
- 10.2.2. By Study Design
- 10.2.3. By Indication
10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Study Design
- 10.3.3. By Indication
10.4. Key Takeaways

11. East Asia Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
  - 11.2.1.1. China
  - 11.2.1.2. Japan
  - 11.2.1.3. South Korea
- 11.2.2. By Study Design
- 11.2.3. By Indication
11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Study Design
- 11.3.3. By Indication
11.4. Key Takeaways

12. South Asia Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
  - 12.2.1.1. India
  - 12.2.1.2. Thailand
  - 12.2.1.3. Malaysia
  - 12.2.1.4. Indonesia
  - 12.2.1.5. Rest of South Asia
- 12.2.2. By Study Design
- 12.2.3. By Indication
12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Study Design
- 12.3.3. By Indication
12.4. Key Takeaways

13. Oceania Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
  - 13.2.1.1. Australia
  - 13.2.1.2. New Zealand
- 13.2.2. By Study Design
- 13.2.3. By Indication
13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Study Design
- 13.3.3. By Indication
13.4. Key Takeaways

14. MEA Virtual Clinical Trials Market Analysis 2017-2021 and Forecast 2022-2032, By Country

14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
  - 14.2.1.1. GCC
  - 14.2.1.2. Rest of MEA
- 14.2.2. By Study Design
- 14.2.3. By Indication
14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Study Design
- 14.3.3. By Indication
14.4. Key Takeaways

15. Key Countries Virtual Clinical Trials Market Analysis

15.1. U.S.
- 15.1.1. Pricing Analysis
- 15.1.2. Market Share Analysis, 2021
  - 15.1.2.1. By Study Design
  - 15.1.2.2. By Indication
15.2. Canada
- 15.2.1. Pricing Analysis
- 15.2.2. Market Share Analysis, 2021
  - 15.2.2.1. By Study Design
  - 15.2.2.2. By Indication
15.3. Brazil
- 15.3.1. Pricing Analysis
- 15.3.2. Market Share Analysis, 2021
  - 15.3.2.1. By Study Design
  - 15.3.2.2. By Indication
15.4. Mexico
- 15.4.1. Pricing Analysis
- 15.4.2. Market Share Analysis, 2021
  - 15.4.2.1. By Study Design
  - 15.4.2.2. By Indication
15.5. Argentina
- 15.5.1. Pricing Analysis
- 15.5.2. Market Share Analysis, 2021
  - 15.5.2.1. By Study Design
  - 15.5.2.2. By Indication
15.6. Germany
- 15.6.1. Pricing Analysis
- 15.6.2. Market Share Analysis, 2021
  - 15.6.2.1. By Study Design
  - 15.6.2.2. By Indication
15.7. Italy
- 15.7.1. Pricing Analysis
- 15.7.2. Market Share Analysis, 2021
  - 15.7.2.1. By Study Design
  - 15.7.2.2. By Indication
15.8. France
- 15.8.1. Pricing Analysis
- 15.8.2. Market Share Analysis, 2021
  - 15.8.2.1. By Study Design
  - 15.8.2.2. By Indication
15.9. U.K.
- 15.9.1. Pricing Analysis
- 15.9.2. Market Share Analysis, 2021
  - 15.9.2.1. By Study Design
  - 15.9.2.2. By Indication
15.10. Spain
- 15.10.1. Pricing Analysis
- 15.10.2. Market Share Analysis, 2021
  - 15.10.2.1. By Study Design
  - 15.10.2.2. By Indication
15.11. Russia
- 15.11.1. Pricing Analysis
- 15.11.2. Market Share Analysis, 2021
  - 15.11.2.1. By Study Design
  - 15.11.2.2. By Indication
15.12. BENELUX
- 15.12.1. Pricing Analysis
- 15.12.2. Market Share Analysis, 2021
  - 15.12.2.1. By Study Design
  - 15.12.2.2. By Indication
15.13. China
- 15.13.1. Pricing Analysis
- 15.13.2. Market Share Analysis, 2021
  - 15.13.2.1. By Study Design
  - 15.13.2.2. By Indication
15.14. Japan
- 15.14.1. Pricing Analysis
- 15.14.2. Market Share Analysis, 2021
  - 15.14.2.1. By Study Design
  - 15.14.2.2. By Indication
15.15. South Korea
- 15.15.1. Pricing Analysis
- 15.15.2. Market Share Analysis, 2021
  - 15.15.2.1. By Study Design
  - 15.15.2.2. By Indication
15.16. India
- 15.16.1. Pricing Analysis
- 15.16.2. Market Share Analysis, 2021
  - 15.16.2.1. By Study Design
  - 15.16.2.2. By Indication
15.17. Thailand
- 15.17.1. Pricing Analysis
- 15.17.2. Market Share Analysis, 2021
  - 15.17.2.1. By Study Design
  - 15.17.2.2. By Indication
15.18. Malaysia
- 15.18.1. Pricing Analysis
- 15.18.2. Market Share Analysis, 2021
  - 15.18.2.1. By Study Design
  - 15.18.2.2. By Indication
15.19. Indonesia
- 15.19.1. Pricing Analysis
- 15.19.2. Market Share Analysis, 2021
  - 15.19.2.1. By Study Design
  - 15.19.2.2. By Indication
15.20. Australia
- 15.20.1. Pricing Analysis
- 15.20.2. Market Share Analysis, 2021
  - 15.20.2.1. By Study Design
  - 15.20.2.2. By Indication
15.21. New Zealand
- 15.21.1. Pricing Analysis
- 15.21.2. Market Share Analysis, 2021
  - 15.21.2.1. By Study Design
  - 15.21.2.2. By Indication
15.22. GCC Countries
- 15.22.1. Pricing Analysis
- 15.22.2. Market Share Analysis, 2021
  - 15.22.2.1. By Study Design
  - 15.22.2.2. By Indication

16. Market Structure Analysis

16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
- 16.3.1. By Regional
- 16.3.2. By Study Design
- 16.3.3. By Indication

17. Competition Analysis

17.1. Competition Deep Dive
- 17.1.1. ICON, plc
  - 17.1.1.1. Overview
  - 17.1.1.2. Product Portfolio
  - 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.1.4. Sales Footprint
  - 17.1.1.5. Strategy Overview
    - 17.1.1.5.1. Marketing Strategy
    - 17.1.1.5.2. Product Strategy
    - 17.1.1.5.3. Channel Strategy
- 17.1.2. Parexel International Corporation
  - 17.1.2.1. Overview
  - 17.1.2.2. Product Portfolio
  - 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.2.4. Sales Footprint
  - 17.1.2.5. Strategy Overview
    - 17.1.2.5.1. Marketing Strategy
    - 17.1.2.5.2. Product Strategy
    - 17.1.2.5.3. Channel Strategy
- 17.1.3. IQVIA
  - 17.1.3.1. Overview
  - 17.1.3.2. Product Portfolio
  - 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.3.4. Sales Footprint
  - 17.1.3.5. Strategy Overview
    - 17.1.3.5.1. Marketing Strategy
    - 17.1.3.5.2. Product Strategy
    - 17.1.3.5.3. Channel Strategy
- 17.1.4. Covance
  - 17.1.4.1. Overview
  - 17.1.4.2. Product Portfolio
  - 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.4.4. Sales Footprint
  - 17.1.4.5. Strategy Overview
    - 17.1.4.5.1. Marketing Strategy
    - 17.1.4.5.2. Product Strategy
    - 17.1.4.5.3. Channel Strategy
- 17.1.5. PRA Health Sciences
  - 17.1.5.1. Overview
  - 17.1.5.2. Product Portfolio
  - 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.5.4. Sales Footprint
  - 17.1.5.5. Strategy Overview
    - 17.1.5.5.1. Marketing Strategy
    - 17.1.5.5.2. Product Strategy
    - 17.1.5.5.3. Channel Strategy
- 17.1.6. LEO Innovation Lab
  - 17.1.6.1. Overview
  - 17.1.6.2. Product Portfolio
  - 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.6.4. Sales Footprint
  - 17.1.6.5. Strategy Overview
    - 17.1.6.5.1. Marketing Strategy
    - 17.1.6.5.2. Product Strategy
    - 17.1.6.5.3. Channel Strategy
- 17.1.7. Medidata
  - 17.1.7.1. Overview
  - 17.1.7.2. Product Portfolio
  - 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.7.4. Sales Footprint
  - 17.1.7.5. Strategy Overview
    - 17.1.7.5.1. Marketing Strategy
    - 17.1.7.5.2. Product Strategy
    - 17.1.7.5.3. Channel Strategy
- 17.1.8. Oracle
  - 17.1.8.1. Overview
  - 17.1.8.2. Product Portfolio
  - 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.8.4. Sales Footprint
  - 17.1.8.5. Strategy Overview
    - 17.1.8.5.1. Marketing Strategy
    - 17.1.8.5.2. Product Strategy
    - 17.1.8.5.3. Channel Strategy
- 17.1.9. CRF Health
  - 17.1.9.1. Overview
  - 17.1.9.2. Product Portfolio
  - 17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.9.4. Sales Footprint
  - 17.1.9.5. Strategy Overview
    - 17.1.9.5.1. Marketing Strategy
    - 17.1.9.5.2. Product Strategy
    - 17.1.9.5.3. Channel Strategy
- 17.1.10. Clinical Ink
  - 17.1.10.1. Overview
  - 17.1.10.2. Product Portfolio
  - 17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.10.4. Sales Footprint
  - 17.1.10.5. Strategy Overview
    - 17.1.10.5.1. Marketing Strategy
    - 17.1.10.5.2. Product Strategy
    - 17.1.10.5.3. Channel Strategy
- 17.1.11. Medable, Inc.
  - 17.1.11.1. Overview
  - 17.1.11.2. Product Portfolio
  - 17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
  - 17.1.11.4. Sales Footprint
  - 17.1.11.5. Strategy Overview
    - 17.1.11.5.1. Marketing Strategy
    - 17.1.11.5.2. Product Strategy
    - 17.1.11.5.3. Channel Strategy

バーチャル臨床試験の世界市場：試験デザイン別、適応症別、地域別（2022年～2032年）

Global Virtual Clinical Trials Market by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Others), and by Region - 2022 to 2032

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 市場の背景

第4章 世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）

第5章 世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：試験デザイン別

第6章 世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：適応別

第7章 世界のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：地域別

第8章 北米のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第9章 ラテンアメリカのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第10章 欧州のバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第11章 東アジアのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第12章 南アジアのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第13章 オセアニアのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第14章 中東・アフリカのバーチャル臨床試験市場の分析（2017年～2021年）・予測（2022年～2032年）：国別

第15章 主要国のバーチャル臨床試験市場分析

第16章 市場構造分析

第17章 競合分析

第18章 前提条件と頭字語の使用

第19章 調査手法